Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1

Related articles

1. A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins

   This article has 16 authors:

   1. Eduard Puente-Massaguer
   2. Thales Galdino Andrade
   3. Michael J. Scherm
   4. Kirill Vasilev
   5. Hassanein Abozeid
   6. Alesandra J. Rodriguez
   7. Josh Yueh
   8. Disha Bhavsar
   9. John D. Campbell
   10. Dong Yu
   11. Richard J. Webby
   12. Yoshihiro Kawaoka
   13. Gabriele Neumann
   14. Julianna Han
   15. Andrew B. Ward
   16. Florian Krammer

2. Sequential Aerosol and Oral Immunization with a Bivalent H9N2/H5N2 Vaccine Protects Against H5N1 and H9N2 Avian Influenza Challenges

   This article has 8 authors:

   1. Flavio Cargnin Faccin
   2. L. Claire Gay
   3. Dikshya Regmi
   4. Robert Hoelzl
   5. Teresa D. Mejías
   6. Darrell Kapczynski
   7. Florian Krammer
   8. Daniel R. Perez

3. Stabilization of H5 highly pathogenic avian influenza hemagglutinin improves vaccine-elicited neutralizing antibody responses

   This article has 13 authors:

   1. Annie Dosey
   2. Bernadeta Dadonaite
   3. Rebecca A. Gillespie
   4. Elizabeth M. Leaf
   5. Matthew J. Vukovich
   6. Jackson McGowan
   7. Emily Grey
   8. Hiromi Muramatsu
   9. Rachel H. J. Jun
   10. Norbert Pardi
   11. Masaru Kanekiyo
   12. Jesse D. Bloom
   13. Neil P. King